FDA Import Refusal SCS-0405203-5/11/5 — ECSTASY HEALTHCARE PRIVATE LIMITED
The FDA refused shipment SCS-0405203-5/11/5 from ECSTASY HEALTHCARE PRIVATE LIMITED (India) on Oct 3, 2023. The refused product falls under Drugs and Biologics — OFLOXACIN (ANTI-BACTERIAL, PART II) (NOT ANTIBIOTIC). Cited charges: 118,75
Refusal details
- Date
- Oct 3, 2023
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61GDA85 OFLOXACIN (ANTI-BACTERIAL, PART II) (NOT ANTIBIOTIC)
- Charges
- 118,75